• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性前列腺癌的放射治疗。

Radiation therapy of localized prostate cancer.

作者信息

Landmann C

机构信息

Department of Radiation-Oncology, University Hospital Petersgraben, Basel, Suisse.

出版信息

Ann Urol (Paris). 1994;28(4):207-20.

PMID:7979211
Abstract

External beam radiation therapy is an effective, well tolerated treatment modality for localized prostate cancer with a low rate of severe morbidity. In this retrospective analysis experience with 431 patients who have been treated with definitive radiation therapy with aim at cure is presented. Median follow-up time was 4 years (range 1-17 years). Treatment was administered with 45 mega Volt photons in all cases. Does between 60-70 Gray to the prostate and 45-50 Gray to the pelvic lymph nodes have been applied. Disease-free survival rates approaching 80% in 5 years and 53% in 10 years have been achieved for disease confined to the prostate as compared to 50% at 5 years and 27% at 10 years for extracapsular disease. The prognostic significance of various factors such as stage, grade, lymph node status, method of diagnosis, and pretreatment prostate-specific antigen value has been documented and analysed. Comparison of results with those of radical prostatectomy is discussed.

摘要

外照射放疗是一种治疗局限性前列腺癌的有效且耐受性良好的治疗方式,严重并发症发生率较低。本文呈现了对431例接受根治性放疗以治愈为目的患者的回顾性分析经验。中位随访时间为4年(范围1至17年)。所有病例均采用45兆伏光子进行治疗。已对前列腺给予60至70格雷的剂量,对盆腔淋巴结给予45至50格雷的剂量。局限于前列腺的疾病5年无病生存率接近80%,10年为53%,而包膜外疾病5年为50%,10年为27%。已记录并分析了诸如分期、分级、淋巴结状态、诊断方法和治疗前前列腺特异性抗原值等各种因素的预后意义。还讨论了与根治性前列腺切除术结果的比较。

相似文献

1
Radiation therapy of localized prostate cancer.局限性前列腺癌的放射治疗。
Ann Urol (Paris). 1994;28(4):207-20.
2
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.
3
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.在前列腺特异性抗原时代,pTXNO前列腺癌的淋巴结清扫范围不影响前列腺癌的预后。
J Urol. 2005 Apr;173(4):1121-5. doi: 10.1097/01.ju.0000155533.93528.4c.
4
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.一项比较根治性前列腺切除术加内分泌治疗与外照射放疗加内分泌治疗对局部晚期前列腺癌疗效的随机试验:中位随访102个月的结果
Jpn J Clin Oncol. 2006 Dec;36(12):789-93. doi: 10.1093/jjco/hyl115. Epub 2006 Nov 2.
5
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.接受盆腔淋巴结清扫术和根治性前列腺切除术治疗的前列腺癌伴淋巴结转移患者的长期随访:辅助放疗的积极影响
Eur Urol. 2009 May;55(5):1003-11. doi: 10.1016/j.eururo.2009.01.046. Epub 2009 Feb 4.
6
Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.接受光疗和早期睾丸切除术治疗的临床C期前列腺癌患者的长期结果。169例病例的回顾性分析。
Strahlenther Onkol. 1996 Nov;172(11):596-603.
7
Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation.前列腺癌同步放疗:125I前列腺植入后行体外照射。
Cancer J Sci Am. 1998 Nov-Dec;4(6):359-63.
8
Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.接受高剂量适形外照射放疗的60岁以下前列腺癌男性患者,其生化无病生存率得到改善。
J Urol. 2003 Nov;170(5):1828-32. doi: 10.1097/01.ju.0000093720.46502.24.
9
Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.对于具有不良病理特征的前列腺癌患者,根治性前列腺切除术后辅助放疗可改善生化结局。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24. doi: 10.1016/j.ijrobp.2004.06.018.
10
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.在前列腺特异性抗原(PSA)时代,接受根治性放疗的局限性前列腺癌患者的治疗年份作为无复发生存的独立预测因素。
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):795-9. doi: 10.1016/j.ijrobp.2005.03.029. Epub 2005 May 31.

引用本文的文献

1
[Rate of PSA increase after radiotherapy as an indication of local recurrence or distant metastasis of prostatic carcinoma].[放疗后前列腺特异抗原(PSA)升高率作为前列腺癌局部复发或远处转移的指标]
Strahlenther Onkol. 1998 Jul;174(7):383-4. doi: 10.1007/BF03038355.